HTA - 12/01/38

Add-Aspirin Trial: A phase III double-blind placebo-controlled randomized trial assessing the addition of aspirin after standard primary therapy in early stage common solid tumours

Project title: Add-Aspirin Trial: A phase III double-blind placebo-controlled randomized trial assessing the addition of aspirin after standard primary therapy in early stage common solid tumours

Call to action: 12/01 12/01 HTA CET Open Call

Research type: Primary Research

Chief investigator: Professor Ruth Langley

Contractor: University College London

Cost: £3,124,812.00

Co-investigators: Dr Alistair Ring, Dr Duncan Gilbert, Dr Fay Cafferty, Dr Michael Chapman, Dr Richard Hubner, Dr Sudeep Gupta, Mr Paul Cathcart, Professor Conjeevaram Pramesh, Professor David Cameron, Professor Howard Kynaston, Professor Janusz Jankowski, Professor Mahesh Parmar, Professor Richard Wilson, Professor Timothy Iveson.

Started: May 2014 | Status: Research in progress

ISRCTN: 74358648

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.